Correction to: Scientific Reports https://doi.org/10.1038/s41598-022-10641-x, Published on 28 April 2022
The original version of this Article contained errors in Figure 6 where the labels for the y-axis were incorrectly given in Japanese characters in Panels (b) and (c). The original Figure 6 and accompanying legend appear below.
The original Article has been corrected.
sEH vaccine was safely administrated in rats. (a) A representative photomicrograph of hematoxylin and eosin staining in heart, lung, kidney, and liver. Scale bars = 100 μm. (b) The mean blood pressure at 11 weeks of age before MI induction. Saline group (n = 10), vaccine group (n = 11). (c) The mean heart rates at 11 weeks of age before MI induction. Saline group (n = 10), vaccine group (n = 11).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Kitsuka, T., Shiraki, A., Oyama, J. et al. Author Correction: A novel soluble epoxide hydrolase vaccine protects murine cardiac muscle against myocardial infarction. Sci Rep 12, 7737 (2022). https://doi.org/10.1038/s41598-022-12232-2
Published:
Version of record:
DOI: https://doi.org/10.1038/s41598-022-12232-2
